MiR-124 changes the sensitivity of lung cancer cells to cisplatin through targeting STAT3

M-M Qi1, F Ge, X-J Chen

  • 1School of Basic Medicine, Nanjing University of Chinese Medicine, Nanjing, China. 718171345@qq.com.

Abstract

Insights

MicroRNA-124 (miR-124) is downregulated in non-small cell lung cancer (NSCLC) drug resistance. Restoring miR-124 enhances cisplatin sensitivity and inhibits NSCLC cell invasion and metastasis by targeting STAT3.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Drug resistance in non-small cell lung cancer (NSCLC) poses a significant clinical challenge.
  • MicroRNAs (miRNAs) play crucial roles in cancer progression and drug response.
  • The specific role of miR-124 in NSCLC chemoresistance remains to be fully elucidated.

Purpose of the Study:

  • To investigate the role of microRNA-124 (miR-124) in the development of drug resistance in non-small cell lung cancer (NSCLC).
  • To explore the underlying molecular mechanism by which miR-124 influences NSCLC chemoresistance.
  • To assess miR-124's potential as a therapeutic target for overcoming cisplatin resistance in NSCLC.

Main Methods:

  • Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and Western blotting were used to measure miR-124 and STAT3 expression levels in NSCLC cells.
  • Cell lines were transfected with miR-124 mimics to overexpress miR-124.
  • Cellular sensitivity to cisplatin, apoptosis, invasion, and metastasis were assessed using MTT assays, flow cytometry, wound healing, and Transwell assays, respectively. Luciferase reporter gene assays were employed to confirm the interaction between miR-124 and STAT3.

Main Results:

  • Expression of miR-124 was significantly lower, while signal transducer and activator of transcription 3 (STAT3) expression was significantly higher in cisplatin-resistant NSCLC cells (A549/DDP) compared to sensitive cells (A549).
  • Overexpression of miR-124 in A549/DDP cells reduced STAT3 expression, enhanced sensitivity to cisplatin, and inhibited cell invasion and metastasis.
  • Luciferase reporter assays confirmed that miR-124 directly targets the 3'-untranslated region (UTR) of STAT3, leading to its negative regulation.

Conclusions:

  • MiR-124 plays a critical role in regulating the sensitivity of non-small cell lung cancer (NSCLC) to cisplatin chemotherapy.
  • MiR-124 inhibits NSCLC cell invasion and metastasis by targeting and downregulating STAT3 expression.
  • STAT3 represents a potential therapeutic target for overcoming cisplatin resistance in NSCLC, with miR-124 serving as a key regulator in this process.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.2K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.2K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
1.2K